Global Blood Therapeutics Buy Hold or Sell Recommendation
| GBTDelisted Stock | USD 68.49 0.00 0.00% |
Considering the 90-day investment horizon and your above-average risk tolerance, our recommendation regarding Global Blood Therapeutics is 'Not Rated'. Macroaxis provides Global Blood buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding GBT positions. The advice algorithm takes into account all of Global Blood's available fundamental, technical, and predictive indicators you will find on this site. Key drivers impacting Global Blood's buy or sell advice are summarized below:
Real Value 50.55 | Hype Value 68.49 | Market Value 68.49 |
A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Global Blood Therapeutics given historical horizon and risk tolerance towards Global Blood. When Macroaxis issues a 'buy' or 'sell' recommendation for Global Blood Therapeutics, the advice is generated through an automated system that utilizes algorithms and statistical models.
Global |
Execute Global Blood Buy or Sell Advice
The Global recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Global Blood Therapeutics. Macroaxis does not own or have any residual interests in Global Blood Therapeutics or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Global Blood's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Not Rated
Global Blood Trading Alerts and Improvement Suggestions
| Global Blood is not yet fully synchronised with the market data | |
| Global Blood has a very high chance of going through financial distress in the upcoming years | |
| The company reported the last year's revenue of 210.87 M. Reported Net Loss for the year was (309.58 M) with profit before taxes, overhead, and interest of 191.43 M. | |
| Global Blood Therapeutics has about 553.42 M in cash with (249.41 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 8.5. | |
| Over 97.0% of the company shares are owned by institutional investors |
Global Blood current analysts advice
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Global analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Global analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
| Target Mean Price | 59.53 | |
| Target Median Price | 65.00 | |
| Target High Price | 102.00 | |
| Recommendation Mean | 1.90 | |
| Number Of Analyst Opinions | 19 | |
| Target Low Price | 31.00 |
The consensus estimates and target price estimation comprises individual analyst assessments, and may or may not mutch the Macroaxis buy or sell advice. It is determined by taking an average of all analyst recommendations and classifying them as Strong Buy, Buy, Hold, or Sell.
| Symbol | GBT |
| Name | Global Blood Therapeutics |
| Type | Stock |
| Country | United States |
| Exchange | NASDAQ |
Information on Global Blood Therapeutics Advice is currently not available.
If you believe this information is not accurate please let us know and we will check it out. Check all delisted instruments across multiple markets.Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Thematic Opportunities
Explore Investment Opportunities
Global Blood Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Global . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Global Blood Buy or Sell Advice
When is the right time to buy or sell Global Blood Therapeutics? Buying financial instruments such as Global Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Global Blood in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Software Thematic Idea Now
Software
Companies that develop and distribute software and software systems to individuals or business. The Software theme has 46 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Software Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics. Note that the Global Blood Therapeutics information on this page should be used as a complementary analysis to other Global Blood's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Other Consideration for investing in Global Stock
If you are still planning to invest in Global Blood Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Global Blood's history and understand the potential risks before investing.
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Global Correlations Find global opportunities by holding instruments from different markets |